logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
25/09/2025
The stock price of Oracle fell by over 1% before the market closed, after the company announced plans to issue 18 billion US dollars of bonds.
Latest
1 m ago
Yuguang Gold Lead: Ultra-high purity tellurium, cadmium, and indium products with a purity of 7N have been prepared and are currently coordinating with downstream customers for product trials.
2 m ago
Yiteng Pharmaceuticals' Hong Kong stock listing approved by China Securities Regulatory Commission.
2 m ago
Accenture reported adjusted earnings of $3.03 per share for the fourth quarter.
2 m ago
Accenture reported adjusted earnings per share of $3.03 for the fourth quarter.
2 m ago
Shanghai Pharmaceuticals (02607): Shanghai Pharmaceuticals transfers 40% equity of Shanghai Pharmaceuticals Group to Shanghai SIS in the Yangtze River Delta region for approximately 6.7215 billion yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.